The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
board of directors and senior management 2023
christian schaffalitzky; executive chairman
iain rawlinson; independent non-executive director
tamerlan abdikeev; non-executive director
kotaro kosaka; independent non-executive director
artem matyushok; independent non-executive director
dmitry suschov; mergers and acquisitions officer
konstantin firstov; ceo kola & country manager
vasily kudrin; ceo west kytlim & in charge of pre-sale activities
we have all of the above and god knows how many other “experts” advising us yet here we are with no sign of a sale of anything.
you’d think one of them would say to cs that the current strategy is fecking useless, from a shareholders point of view something needs to change and cs needs to get this **** sorted. there’s only so long they can use the nda excuses, if any of them aren’t up to the task do us a favour and feck off and let someone take over who can. basic clear communication to their shareholders & markets would be a good starting point.
I really think posters should start contacting the company by telephone (email is useless) to discuss things and give them your opinion on things, I feel sorry for Keith as he’s the only person we can contact and his hands are tied. Far too many people on here state things like “it’s an easy waiting game” that’s not the impression I got yesterday when I called! I’ve got no sympathy for the BOD as imo their communication is shocking and this has directly contributed to the SP decline due to far too much information missing. I won’t list it all as DR will get upset 😉 Trav licence is the latest example though, have we had any official confirmation on that licence approval and explanation as to why it’s gone to KK? There’s far too many unknowns here and shareholders are been treated very poorly.
@B1ll; I’d be happy with a “credit note” right now for the sale of the assets. It can’t be any worse than watching the SP decline slowly & getting drip fed bits of info from our current BOD. I spoke with Keith today to air my views on everything and he sounds down, before anyone asks if you want to know anything give him a call yourself.
@DR; unlike yourself I don’t need to come on here & spout lie after lie to try to make myself appear important. I’ve got plenty shares but granted nowhere near your levels of around 18M (supposedly). You claim you’re comfortable with the current situation with EUA so I have to ask why are you here all day every day attacking anyone who dares to question the BOD? You’re a Walter Mitty who clearly needs to get a real life.
I wonder how things are progressing with resolving the disputed invoices of approximately £108,000 with Gowling WLG (UK) LLP, the Company's former legal advisers.
You’d think it’d be in everyone’s best interest to resolve the matter amicably and without recourse to further legal proceedings.
3 weeks on and yet again no update from our BOD on a subject which resulted in a 26% drop in the SP.
As requested by Dim is he;
1. 12th May 2021; received a proposal from a credible party & exited the FSP 924 days ago.
2. Asset sale; (28 Oct 2021) buyers DD complete 755 days ago.
3. NKT JORC; (16 Dec 2021) Work on the open pit part is in progress and the NPV of that part will be announced separately 706 days ago.
4. NYUD JORC; (8 Feb 2022 draft CPR with BOD for review) 652 days ago.
5. Nyud; Exploration license received by Rosgeo in mid Dec 2022, EUA will update shareholders on receipt of this license in due course. Approx 338 days ago.
6. 3 July 2023 MT DFS approved; 141 days ago.
7. MT royalty payment due by Nov (16.68 million roubles).
@DR, I was always told that intelligent people ask questions and the gullible ones go along with what they’re told. I’m a nobody on here as is everyone but I don’t need to make stuff up to try to pretend to be somebody important like you do… would you like a list? 😉
@DR; in what way have I been ousted? I stated that the rest of the BOD have achieved nothing for EUA, no one’s shown me anything to change that view. When they achieve a sale of the assets I will change my opinion depending on what the sale price is.
@DR; why do you need to respond on behalf of IKN. A bit rich you accusing another poster of resorting to personal attacks as that’s usually your area of expertise. I’d guess you’re referencing the fact I called him “thick” for his comment on DS who isn’t on the BOD (maybe do some of your own research on that)
@IKN; I was talking about the current BOD (minus CS) Are you that thick that you can’t figure out that doesn’t include DS? With regards to the rest, I can’t see anything they've achieved for EUA, Artemis certainly not sped up the asset sale & the Japan office isn’t doing very much. I’m sure you’ll know much more with your contacts but imo they’re not achieving much.
@Makeabundle; I’ve no interest in POAZ as we don’t own it and it looks like we never will. I think it’s more important to focus on what we do have and figure out what’s happening with them;
WK, MT, NKT (no idea what’s happening with Trav) & NYUD (EUAs rights to 75% of the licence)
Beyond those I have no interest, sell the above assets, pay out a dividend and forget about EUA v2. CS will retire, the rest of the BOD have achieved nothing for the company.
They may have sold the concentrate & id not be shocked if they just haven’t bothered to tell us yet. That said, are we positive that the concentrate & VAT credits would come into EUAs £ or $ bank account or the WK subs paid in Russian Roubles?
We’ve got the US treasury notes of circa £1.5M but I’ve no idea if that’s easily accessible.
MrYFronts; yeah, Impossible to know the exact figure unless we know when it was paid, it’s a big chunk of the £400,000 we had in July though on top of 3 months BOD salaries, WUP & QVL court case costs. I’m sure the BOD have it all in hand.
@Spikeyj;
Looks like the got the number wrong in 2021 AR, it should read 16.68M not 6.68M 🤬
Here’s the 2022 AR, page 64.
“At the time of the award of the Monchetundra mining licence a royalty payment was calculated by the Russian Federal Reserves Commission. 20% of this payment was paid in December 2018 and the remaining 80%, or RR16.68 million (approximately £187,000) to be paid by November 2023.”